RE:RE:Did CXR Overpay for Amdipharm Mercury...?Thank you for posting. This is a reasonable take on CXR debt levels and valuation. Earnings in a couple of weeks will provide the clarity we all seek. If guidance is met or exceeded and company announces further debt repayments, this stock should see a nice and steady climb above $60 in a relatively short period of time.